tiprankstipranks
3 Best Stocks to Buy Now, 11/4/2024, According to Top Analysts 
Market News

3 Best Stocks to Buy Now, 11/4/2024, According to Top Analysts 

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well.

Pick the best stocks and maximize your portfolio:

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. 

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio. 

Genius Sports (GENI) – This sports data and technology company provides real-time data, analytics, and digital content solutions to sports leagues, media, and betting companies. Today, JMP Securities analyst Jordan Bender maintained a Buy rating on the stock with a price target of $9. In the last three months, all six Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of over 41%.

nVent Electric (NVT) – nVent Electric provides electrical connection and protection solutions. Today, Barclays analyst Julian Mitchell reiterated a Buy rating on the stock with a price target of $76. In the last three months, four out of the five Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of over 24%.

Eli Lilly (LLY) – This global pharmaceutical company develops innovative medicines for diabetes, cancer, and neurodegenerative diseases. Today, Barclays analyst Carter Gould reiterated a Buy rating on the stock with a price target of $975. In the last three months, 10 out of the 11 Top Analysts covering the stock have rated it a Buy. Altogether, their 12-month price targets imply an upside of over 27%.

Who Are the Top Analysts? 

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. 

See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page. 

Disclosure 

Related Articles
TheFlyEli Lilly announces FDA approval for Zepbound for obstructive sleep apnea
TheFlyEli Lilly announces FDA approval for Zepbound
TheFlyBMO lowers Novo Nordisk price target to $105, says reaction to data ‘overdone’
Go Ad-Free with Our App